1. Home
  2. SCZM vs TECX Comparison

SCZM vs TECX Comparison

Compare SCZM & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Santacruz Silver Mining Ltd. Common Shares

SCZM

Santacruz Silver Mining Ltd. Common Shares

N/A

Current Price

$9.18

Market Cap

585.2M

Sector

N/A

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$31.36

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCZM
TECX
Founded
N/A
2019
Country
Canada
United States
Employees
455
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
585.2M
618.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SCZM
TECX
Price
$9.18
$31.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$75.20
AVG Volume (30 Days)
497.8K
215.6K
Earning Date
05-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.70
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$79.38
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.61
$14.39
52 Week High
$17.65
$39.53

Technical Indicators

Market Signals
Indicator
SCZM
TECX
Relative Strength Index (RSI) 57.73 44.22
Support Level $8.64 $27.30
Resistance Level $10.15 $31.39
Average True Range (ATR) 0.54 2.57
MACD -0.06 -0.54
Stochastic Oscillator 42.40 24.37

Price Performance

Historical Comparison
SCZM
TECX

About SCZM Santacruz Silver Mining Ltd. Common Shares

Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapa mine and processing plant, and Corporate and Other activities. Key revenue is generated from Zimapan.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: